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Participants were from the RugbyGene project, comprising
elite Caucasian male rugby athletes (n = 528; mean (standard
deviation) height 1.85 (0.07) m, mass 101 (14) kg, age 29 (7)
yr), including 420 rugby union (RU) athletes that for some
analyses were divided into forwards and backs and 108 rugby
league (RL) athletes. Non-athletes were 592 Caucasian men
and women (57% male, height 1.72 (0.10) m, mass 74 (14) kg,
age 31 (7) yr). PCR of genomic DNA was used to determine
genotypes using TaqMan probes, then groups were compared
using χ2 and odds ratio (OR) statistics.
Incidence and outcomes of concussions have been
hypothesised to be genetically influenced. Within rugby, the
primary mechanical stress injury to neurons is often a result of
a collision and can initiate the secondary (delayed) injury of a
neurometabolic cascade, resulting in neuropathologic events.
The APOE promoter G219T (rs405509) polymorphism has
been associated with differential promoter activity and
unfavourable outcomes after traumatic brain injury. The TT
genotype has been associated with a 3-fold greater risk of
multiple concussions3. The TT genotype of MAPT (rs10445337)
has also been associated with poorer outcomes after
concussion2, potentially due to the formation of neurotoxic
neurofibrillary tangles1. Rugby has one of the highest
incidences of concussion in sport, so it was hypothesised that
APOE promoter TT and MAPT TT genotypes would be less
prevalent in elite rugby athletes because those genotypes,
previously associated with increased risk, would be less
compatible with achieving elite athlete status.
Introduction
Method
The MAPT (rs10445337) TT genotype is 6% less common in
elite rugby athletes than non-athletes. Therefore, carrying at
least one rs10445337 C allele appears to increase the
probability of sustained career success in the high-risk
concussion environment of elite rugby, perhaps via a greater
ability to recover from concussions.
Results
All genotype data were in Hardy-Weinberg equilibrium. For
MAPT (rs10445337), the risk genotype (TT) was
underrepresented in rugby athletes (60%) compared to non-
athletes (66%), CT more common in rugby athletes (34%) than
non-athletes (29%) and little difference in CC genotype
frequencies (χ2 = 7.092, P = 0.029; TT genotype frequency OR
= 0.80, 95% confidence intervals (CI) = 0.62-1.02). There were
no differences in MAPT (rs10445337) genotype frequencies
between RU forwards and backs (Fig 1). For APOE promoter
G219T (rs405509), there were no differences in genotype
frequencies between all athletes (RU and RL) and non-athletes
(27% TT genotype in players and non-athletes), nor between
RU forwards and backs (Fig 2).
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Fig. 1 MAPT (rs10445337) genotype frequencies. * Different from 
Non-athletes (P = 0.029)
Fig. 2 APOE promoter G219T (rs405509) genotype frequencies
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